The mineralocorticoid receptor (MR) and renin-angiotensin-aldosterone system (RAAS) are implicated in non-alcoholic liver fatty disease (NALFD). This evidence concerns the gene NR3C2 and metabolic dysfunction-associated steatotic liver disease.